A fluorescence-based reporter substrate for monitoring RNA editing in trypanosomatid pathogens.
RNA editing regulates mitochondrial gene expression in trypanosomatid pathogens by creating functional mRNAs. It is catalyzed by a multi-protein complex (the editosome), and is found to be essential in both insect stage and mammalian blood stream form of Trypanosoma brucei. This particular form of RNA editing is unique to trypanosomatids, and thus provides a suitable drug target in trypanosomatid pathogens. Here, we demonstrate the feasibility of a rapid and sensitive fluorescence-based reporter assay to monitor RNA editing based on ribozyme activity. We could validate our new assay using previously identified inhibitors against the essential RNA editing ligase. The principle advantages of this assay are: (i) the use of non-radioactively labeled materials, (ii) sensitivity afforded by fluorescence instrumentation applicable to high-throughput screening of chemical inhibitors against the essential editosome and (iii) a rapid and convenient 'mix and measure' type of assay in low volume with a high signal to noise ratio. This assay should enhance rapid identification and characterization of the editosome inhibitors primarily based on the overall composition of the editosomes from T. brucei. These inhibitors could also be tested against the editosomes from the closely related pathogens including T. cruzi and Leishmania species.
Moshiri
Houtan
H
Institute of Parasitology, McGill University, 21111 Lakeshore Road, Ste. Anne de Bellevue, Montreal, Quebec H9X3V9, Canada.
Salavati
Reza
R
D019729:Carbon-Oxygen Ligases / Q000037:antagonists & inhibitors; D005453:Fluorescence; D031541:Fluorescence Resonance Energy Transfer; D017393:RNA Editing; D016337:RNA, Catalytic / Q000378:metabolism*; D014346:Trypanosoma brucei brucei / Q000201:enzymology / Q000235:genetics*
D016337:RNA, Catalytic; C427204:hammerhead ribozyme; D019729:Carbon-Oxygen Ligases
RNA. 2003 Apr;9(4):484-92
12649499
Lancet Infect Dis. 2002 Jul;2(7):437-40
12127356
Methods Mol Biol. 2007;372:67-80
18314718
J Biol Chem. 2003 Nov 28;278(48):47526-33
12970369
J Parasitol. 1984 Oct;70(5):747-54
6439844
Mol Cell Biol. 2008 Jan;28(1):122-30
17954557
Science. 1994 Oct 7;266(5182):114-7
7524149
EMBO J. 2002 Apr 2;21(7):1791-9
11927563
Eukaryot Cell. 2003 Jun;2(3):578-87
12796303
Eukaryot Cell. 2002 Feb;1(1):112-8
12455977
J Biomol Screen. 1999;4(2):67-73
10838414
J Clin Invest. 2008 Apr;118(4):1301-10
18382742
EMBO J. 1991 May;10(5):1217-24
1708723
Mol Cell Biol. 2000 Nov;20(22):8447-57
11046141
RNA. 2009 Oct;15(10):1929-38
19696159
RNA. 2008 Feb;14(2):347-58
18065716
Methods Mol Biol. 2004;265:273-91
15103079
EMBO J. 1997 Jul 1;16(13):4069-81
9233816
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16614-9
16269544
RNA. 2006 Jun;12(6):1038-49
16611942
Nat Biotechnol. 2001 Jan;19(1):56-61
11135553
RNA. 2008 Jun;14(6):1187-200
18441050
Methods. 1998 May;15(1):3-14
9614648
Genes Dev. 1994 Mar 15;8(6):720-31
7926762
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17278-83
18981420
Mol Microbiol. 2002 Aug;45(3):591-6
12139607
Mol Cell Biol. 2002 May;22(9):3194-203
11940676
RNA. 2007 May;13(5):737-44
17369311
Drug Resist Updat. 2007 Feb-Apr;10(1-2):30-50
17409013
Biochem Pharmacol. 2001 Jan 1;61(1):1-5
11137702
RNA. 2002 Apr;8(4):548-54
11991648
Science. 2001 Mar 16;291(5511):2159-62
11251122
Mol Cell Biol. 2003 Nov;23(21):7909-19
14560033
Mol Biochem Parasitol. 2003 Apr 3;127(2):161-7
12672525
Mol Cell Biol. 2001 Oct;21(20):6833-40
11564867
Cell. 1996 Mar 22;84(6):831-41
8601307
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12709-14
12228725
Trends Parasitol. 2003 Nov;19(11):488-94
14580959
J Cell Sci. 1999 Sep;112 ( Pt 17):2797-8
10452736
RNA. 2006 May;12(5):819-31
16601201